West Pharmaceutical Services (WST) Total Current Liabilities (2016 - 2025)
Historic Total Current Liabilities for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $654.9 million.
- West Pharmaceutical Services' Total Current Liabilities rose 1898.62% to $654.9 million in Q4 2025 from the same period last year, while for Dec 2025 it was $654.9 million, marking a year-over-year increase of 1898.62%. This contributed to the annual value of $654.9 million for FY2025, which is 1898.62% up from last year.
- Per West Pharmaceutical Services' latest filing, its Total Current Liabilities stood at $654.9 million for Q4 2025, which was up 1898.62% from $635.4 million recorded in Q3 2025.
- In the past 5 years, West Pharmaceutical Services' Total Current Liabilities ranged from a high of $671.8 million in Q4 2023 and a low of $456.7 million during Q3 2022
- For the 5-year period, West Pharmaceutical Services' Total Current Liabilities averaged around $562.8 million, with its median value being $554.5 million (2021).
- Per our database at Business Quant, West Pharmaceutical Services' Total Current Liabilities surged by 4018.58% in 2021 and then crashed by 1876.93% in 2025.
- Quarter analysis of 5 years shows West Pharmaceutical Services' Total Current Liabilities stood at $594.1 million in 2021, then decreased by 12.64% to $519.0 million in 2022, then grew by 29.44% to $671.8 million in 2023, then decreased by 18.07% to $550.4 million in 2024, then grew by 18.99% to $654.9 million in 2025.
- Its Total Current Liabilities stands at $654.9 million for Q4 2025, versus $635.4 million for Q3 2025 and $604.6 million for Q2 2025.